
Most radiologists report few meaningful clinical benefits from current breast imaging AI tools, despite rising adoption.
Key Details
- 1Survey of Society of Breast Imaging members evaluated FDA-cleared breast cancer AI detection tool adoption and impact.
- 2Few radiologists believe current AI contributes significant clinical benefits or decisively improves outcomes.
- 3Although daily use is rising, most users report only minor improvements and little to no financial gain.
- 4A related EuroAIM/EuSoMII 2024 survey found nearly half of respondents use AI, but most saw minimal workload reduction.
- 5Anticipated benefits, like improved outcomes or efficiency, are not widely realized so far in clinical practice.
Why It Matters
This suggests a gap between the promise of AI in breast imaging and its real-world impact, informing future research, tool development, and adoption strategies. Understanding these limitations can guide expectations and investment in imaging AI.

Source
Radiology Business
Related News

•AuntMinnie
Deep Learning PET Biomarkers Outperform Clinical Tools in Prostate Cancer Survival Prediction
Deep learning-derived PET biomarkers more accurately predict metastatic prostate cancer survival than standard clinical risk models.

•AuntMinnie
Multinational AI Model Flags Osteoporosis on Chest X-rays
AI can opportunistically detect osteoporosis from chest x-rays across diverse international populations.

•AuntMinnie
AI Worklist Prioritization Dramatically Reduces MSK Fracture Reporting Times
AI-driven worklist prioritization lowered turnaround times for musculoskeletal fracture detection on radiographs by over 80%.